News

By Tyler Beasley, Executive Director, Business Intelligence Over the last several years, clinical research organizations have invested heavily in business intelligence infrastructure. Enterprise reporting has replaced manually maintained spreadsheets and datasets. Data warehouses have helped to partially bridge the gap with previously disconnected systems. ​​Dashboards now deliver visibility into nearly every aspect of study execution, … Read more

Michael Zimmerman, MD, will tell you that he is impatient, with about as much fanfare as someone might mention they’re left-handed. He chose emergency medicine partly because of that trait: the ER moves fast, emergency medics get to travel in helicopters, and nobody makes you wait two days for a lab result. That fast-paced world … Read more

By Sweta Pittala, VP, Technology Portfolio Management At a Glance Responding to Requests for Proposal (RFPs) is one of the most labor-intensive processes in clinical trial operations. Velocity’s Feasibility Agent automates and augments that process, drawing on years of data on site performance from 70+ global sites, PI experience, and local recruitment trends to produce … Read more

Congratulations to Ipsen on positive Phase IIIb results from the ELSPIRE trial evaluating IQIRVO® (elafibranor) in patients with Primary Biliary Cholangitis (PBC). The trial met its primary endpoint with statistical significance, with 85% of patients treated with IQIRVO achieving ALP normalization versus 23% on placebo — a result with meaningful implications for how the field … Read more

By Nick Spittal, Chief Operations Officer, Velocity Clinical Research How many times have you heard the term AI this week? Sponsors are investing in it, CROs are building for it, and tech vendors are popping up left, right, and center to sell it. Sites are fully in the crosshairs, with hundreds of hours of procurement … Read more

By Andrew Reina, Chief Revenue Officer I spent the better part of two decades on the CRO side of clinical research, which gives you a particular vantage point. You see how sponsors evaluate site networks, what they ask for, and (more tellingly) what they don’t. Historically, this is a transactional relationship; a site’s job is … Read more

Since 2020, Velocity Clinical Research has supported trials that contributed to 61 FDA-approved products — and we couldn’t be more proud of what that represents. Those 61 FDA-approved products span an extraordinary range of therapeutic areas: cardiovascular disease, obesity and diabetes, Alzheimer’s disease, respiratory conditions including RSV and COVID-19, dermatology, liver disease, migraine, multiple sclerosis, … Read more